Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01312935
Recruitment Status : Terminated (PolyMedix decided to stop enrollment in both clinical trials due to observations of reductions in blood pressure.)
First Posted : March 11, 2011
Last Update Posted : May 17, 2012
Information provided by (Responsible Party):
PolyMedix, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : June 2012
  Estimated Study Completion Date : August 2012